Training trial staff in the use of a mixed method assessment of understanding tool in HIV vaccine trials by Mbogua J, Mebrahtu T, Lindegger G, Sabrina W, Anzala O, Mutua G, Mpendo J, Karita E, Singh S

Sensitivity and specificity of HIV rapid tests used for research and voluntary counselling and testing. by Anzala, O, Sanders, E, Kamali, A, Katende, M, Mutua, G, Ruzagira, E, Stevens, G, Simek, M, Price, M

Understanding adherence to daily and intermittent regimens of oral HIV pre-exposure prophylaxis among men who have sex with men in Kenya by Mugo, PM, Sanders, EJ, Mutua, G, van der Elst, E, Anzala, O, Barin, B, Bangsberg, DR, Priddy, FH, Haberer, JE

Utility of different adherence measures for PrEP: Patterns and incremental value by Abaasa, A, Hendrix, C, Gandhi, M, Anderson, P, Kamali, A, Kibengo, F, Sanders, E, Mutua, G, Bumpus, N, Priddy, F, Haberer, J

Uptake and tolerability of repeated mucosal specimen collection in two Phase 1 AIDS preventive vaccine trials in Kenya by Mutua G, Omosa-Manyonyi G, Park H, Bergin P, Laufer D, Amornkul PN, Lehrman J, Fast P, Gilmour J, Anzala O, Farah B

High acceptability of HIV pre-exposure prophylaxis but challenges in adherence and use: qualitative insights from a phase I trial of intermittent and daily PrEP in at-risk populati... by Van der Elst, E, Mbogua, J, Operario, D, Mutua, G, Kuo, C, Mugo, P, Kanungi, J, Singh, S, Haberer, J, Priddy, F, Sanders, E

Safety and adherence to intermittent pre-exposure prophylaxis (PrEP) for HIV-1 in African men who have sex with men and female sex workers. by Mutua, G, Sanders, E, Mugo, P, Anzala, O, Haberer, J, Bangsberg, D, Barin, B, Rooney, J, Mark, D, Chetty, P, Fast, P, Priddy, F

AIDS vaccines and preexposure prophylaxis: is synergy possible? by Excler, J, Rida, W, Priddy, F, Gilmour, J, McDermott, AB, Kamali, A, Anzala, O, Mutua, G, Sanders, E, Koff, W, Berkley, S, Fast, P

Comparing the Novel Method of Assessing PrEP Adherence/Exposure Using Hair Samples to Other Pharmacologic and Traditional Measures. by Baxi, S, Liu, A, Bacchetti, P, Mutua, G, Sanders, E, Kibengo, F, Haberer, J, Rooney, J, Hendrix, C, Anderson, P, Huang, Y, Priddy, F, Gandhi, M

Identifying at-risk populations in Kenya and South Africa: HIV incidence in cohorts of men who report sex with men, sex workers, and youth. by Price, M, Rida, W, Mwangome, M, Mutua, G, Middelkoop, K, Roux, S, Okuku, H, Bekker, L, Anzala, O, Ngugi, E, Stevens, G, Chetty, P, Amornkul, P, Sanders, E

Developing standards of care for HIV prevention research in developing countries – a case study of ten research centers in Eastern and Southern Africa by Ngongo BP, Priddy F, Park H, Bender B, Fast P, Anzala O, Mutua G, Ruzagira E, Kamali A, Karita E, Mugo P, Chomba E, Bekker L, Roux S, Nanvubya A, Mebrahtu T

HIV Type 1 transmission networks among men having sex with men and heterosexuals in Kenya. by Bezemer, D, Faria, N, Hassan, A, Hamers, R, Mutua, G, Anzala, O, Mandaliya, K, Cane, P, Berkley, J, Rinke de Wit, T, Wallis, C, Graham, S, Price, M, Coutinho, R, Sanders, E

Broad HIV-1 inhibition in vitro by vaccine-elicited CD8+T cells in African adults by Cox, J, Farah, B, Langat, R, Indangasi, J, Ogola, S, Onsembe, B, Kopycinski, J, Hayes, P, Borthwick, N, Barin, B, Gilmour, J, De Bont, J, Anzala, O, Fast, P, Reilly, M, Chinyenze, K, Mutua, G, Jaoko, W, Hanke, T, Grp, H

Quantifying rates of HIV-1 flow between risk groups and geographic locations in Kenya: A country-wide phylogenetic study by Nduva, GM, Otieno, F, Kimani, J, Wahome, E, McKinnon, LR, Cholette, F, Majiwa, M, Masika, M, Mutua, G, Anzala, O, Graham, SM, Gelmon, L, Price, MA, Smith, AD, Bailey, RC, Baele, G, Lemey, P, Hassan, AS, Sanders, EJ, Esbjörnsson, J

Transmitted HIV type 1 drug resistance among individuals with recent HIV infection in East and Southern Africa. by Price, M, Wallis, C, Lakhi, S, Karita, E, Kamali, A, Anzala, O, Sanders, E, Bekker, L, Twesigye, R, Hunter, E, Kaleebu, P, Kayitenkore, K, Allen, S, Ruzagira, E, Mwangome, M, Mutua, G, Amornkul, P, Stevens, G, Pond, S, Schaefer, M, Papathanasopoulos, M, Stevens, W, Gilmour, J

Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in healthy and HIV-infected adults: A randomised, placebo-controlled Phase II clinical tr... by Barry, H, Mutua, G, Kibuuka, H, Anywaine, Z, Sirima, SB, Meda, N, Anzala, O, Eholie, S, Bétard, C, Richert, L, Lacabaratz, C, McElrath, MJ, de Rosa, S, Cohen, KW, Shukarev, G, Robinson, C, Gaddah, A, Heerwegh, D, Bockstal, V, Luhn, K, Leyssen, M, Douoguih, M, Thiébaut, R, Thiebaut, R

Broad HIV-1 inhibition in vitro by vaccine-elicited CD8+ T cells in African adults by Mutua, G, Farah, B, Langat, R, Indangasi, J, Ogola, S, Onsembe, B, Kopycinski, J, Hayes, P, Borthwick, N, Ashraf, A, Dally, L, Barin, B, Tillander, A, Gilmour, J, De Bont, J, Crook, A, Hannaman, D, Cox, J, Anzala, O, Fast, P, Reilly, M, Chinyenze, K, Jaoko, W, Hanke, T, HIV-CORE 004 study group

Control of the HIV-1 load varies by viral subtype in a large cohort of African adults with incident HIV-1 infection by Price, M, Rida, W, Kilembe, W, Karita, E, Inambao, M, Ruzagira, E, Kamali, A, Sanders, E, Anzala, O, Hunter, E, Allen, S, Edward, V, Wall, K, Tang, J, Fast, P, Kaleebu, P, Lakhi, S, Mutua, G, Bekker, L, Abu-Baker, G, Tichacek, A, Chetty, P, Latka, M, Maenetje, P, Makkan, H, Kibengo, F, Priddy, F, Gilmour, J

CLSI-derived hematology and biochemistry reference intervals for healthy adults in eastern and southern Africa. by Karita, E, Ketter, N, Price, M, Kayitenkore, K, Kaleebu, P, Nanvubya, A, Anzala, O, Jaoko, W, Mutua, G, Ruzagira, E, Mulenga, J, Sanders, E, Mwangome, M, Allen, S, Bwanika, A, Bahemuka, U, Awuondo, K, Omosa, G, Farah, B, Amornkul, P, Birungi, J, Yates, S, Stoll-Johnson, L, Gilmour, J, Stevens, G, Shutes, E, Manigart, O, Hughes, P, Dally, L, Scott, J, Stevens, W, Fast, P, Kamali, A